Latest News for: receptor 5

Edit

GLP-1 Receptor Agonists Market Gains Momentum as Weight-Loss Drugs Redefine Diabetes and Heart Care - Says Strategic Market Research

PR Newswire 17 Jun 2026
Global GLP-1 Receptor Agonists Market to grow from USD 18.4 billion in 2024 to USD 41.5 billion by 2030 as diabetes treatment, obesity care, cardiovascular risk reduction, oral drug innovation, and payer access reshape metabolic therapeutics.
Edit

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

ACCESSWIRE 17 Jun 2026
Food and Drug Administration (FDA) for Ketamir-2, the Company's proprietary oral NMDA receptor modulator, in chemotherapy-induced peripheral neuropathy (CIPN) ... Ketamir-2 is an oral NMDA receptor modulator in development for chronic neuropathic pain.
Edit

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a ...

Nasdaq Globe Newswire 16 Jun 2026
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at ...
Edit

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological ...

Nasdaq Globe Newswire 15 Jun 2026
ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a ...
Edit

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 (Zymeworks Inc)

Public Technologies 15 Jun 2026
ZW191 is an antibody-drug conjugate engineered to target a protein called folate receptor-⍺ found in ~75% of high-grade serous ovarian carcinomas1, over 50% of endometrial cancers2,3 and ~70% of lung adenocarcinomas4.
Edit

Padres ponen al receptor Freddy Fermin en lista de lesionados por conmoción

Lancaster Online 14 Jun 2026
BALTIMORE (AP) — Los Padres de San Diego colocaron al receptor venezolano Freddy Fermín en la lista de lesionados de 7 días por conmoción cerebral el domingo, un día después de que fuera golpeado en la cabeza por un lanzamiento ... .
Edit

How Does GHRP-6 Nasal Spray Affect GH Receptor Binding

GetNews 13 Jun 2026
They had a compound that clearly worked on a receptor, but the receptor's natural ligand was unknown ... The receptor binding dynamics ... How Does GHRP-6 Bind to the GHS-R1a Receptor?The Receptor Architecture ... From Receptor Binding to GH Release.
Edit

Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use ...

Nasdaq Globe Newswire 11 Jun 2026
(Tris), a commercial-stage biopharmaceutical company, today announced five ...
Edit

G-protein regulatory network governs receptor internalization dynamics

PNAS 09 Jun 2026
At the forefront, G protein–coupled receptors serve to initiate ... .
Edit

Global Consensus Guides Safe Use of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Type 1 Diabetes

Albany Democrat Herald 06 Jun 2026
Off-label use is becoming increasingly common to address weight management, insulin resistance, and complication risks in type 1 diabetes. New expert recommendations provide a framework for safe use while large trials are ongoing ....
Edit

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

PR Newswire 06 Jun 2026
"Beyond AMB-702, Ambrosia's next-generation, small molecule pipeline also includes a once-weekly GLP-1 receptor agonist, a GIP receptor antagonist, and an amylin receptor agonist, all enabling a significant opportunity for combination therapies.".
Edit

First Dual GLP-1\/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood ...

Mississippi Business Journal 06 Jun 2026
NEW ORLEANS, June 5, 2026 /PRNewswire/ -- A new study evaluating the role of acmopatide (CT-868), a once-daily dual glucagon-like peptide 1/gastric inhibitory polypeptide receptor agonist (GLP-1/GIP ...
Edit

What Is the GPR133 Receptor and Can It Really Stop Bone Loss in Its Tracks? ...

The Miami Herald 05 Jun 2026
Researchers found a bone switch that could stop osteoporosis before a fracture happens. Here are the biggest questions answered ... .
×